Back to Newsroom

Catalyst Pharmaceuticals to Present at 15th Annual BIO Investor Forum

CORAL GABLES, Fla., Oct. 13, 2016 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today announced that Patrick J. McEnany, Chief Executive Officer, and Steven Miller, Ph.D., Chief Operating Officer and Chief Scientific Officer, will present at the 15th Annual BIO Investor Forum being held at theWestin St. Francis in San Francisco, October 18-19.

Click here to read the full release